Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Perrigo Company PLC (NYSE:PRGO)

91.39
Delayed Data
As of Jul 29
 +0.31 / +0.34%
Today’s Change
84.85
Today|||52-Week Range
198.42
-36.84%
Year-to-Date
Jerome Dodson Comments on Perrigo
Jul 26 / GuruFocus News - Paid Partner Content
3 Stocks That Have Been Cut in Half Over the Past Year
Jul 25 / MotleyFool.com - Paid Partner Content
Jerome Dodson's Parnassus Fund 2nd Quarter Commentary
Jul 26 / GuruFocus News - Paid Partner Content
5 Big Pharma Stocks Struggling to Raise Their Dividends
Jul 19 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close91.08
Today’s open91.26
Day’s range90.10 - 91.79
Volume1,260,207
Average volume (3 months)2,651,813
Market cap$13.1B
Dividend yield0.63%
Data as of 4:02pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-95.67%
Earnings growth (this year)--
Earnings growth (next 5 years)+7.40%
Revenue growth (last year)+36.36%
P/E ratio19.3
Price/Sales3.82
Price/Book1.30

Competitors

 Today’s
change
Today’s
% change
MDVNMedivation Inc+1.50+2.40%
BMRNBiomarin Pharmaceuti...+1.22+1.24%
INCYIncyte Corp+2.09+2.37%
JAZZJazz Pharmaceuticals...-1.85-1.21%
Data as of 3:59pm ET, 07/29/2016

Financials

Next reporting dateAugust 31, 2016
EPS forecast (this quarter)$1.99
Annual revenue (last year)$5.5B
Annual profit (last year)$11.2M
Net profit margin0.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
John T. Hendrickson
Chief Financial Officer &
Executive Vice President
Judy L. Brown
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers

Search for Jobs